Arize AI vs Insilico Medicine

Arize AI — Infrastructure · Private · 1 of 1 figure sourced  |  Insilico Medicine — Application · Public · $4.3B mkt cap · 5 of 5 figures sourced

Relationship

Assembled from the recorded fields for this pair, not hand-checked. The comparison below is read from each company’s own profile.

Aligned comparison

FieldArize AIInsilico Medicine
Sizenot disclosed$4.3B mkt cap
Employees—333
Founded20202014 6 yrs earlier
StatusPrivatePublic
CategoryInfrastructureApplication
Stack layerAI agent, Developer tool, Infrastructure service, PlatformApplication, Hardware, Platform
HeadquartersBerkeley, USAHong Kong

Capability overlap

Shared · 3

Agent orchestrationData analysisEvaluation and observability

Not verified for Arize AI · 5

Drug discoveryModel trainingKnowledge retrievalSummarizationText generation

Recorded for Insilico Medicine. Arize AI’s product records say nothing either way — a missing record is not a missing capability.

Arize AI has no capability Insilico Medicine lacks, among the 3 recorded here.

Products, side by side

Algorithmic pairing — assembled from recorded fields, not hand-checked

Arize AI

Platform

Arize AXPlatform

AI observability platform that traces, evaluates and monitors machine-learning and LLM applications in production, surfacing issues and root causes.

Insilico Medicine

Platform

Biology42: Generative BiologicsPlatform

AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.

Chemistry42Platform

Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.

MMAI GymPlatform

Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.

PandaOmicsPlatform

AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base.

Pharma.AIPlatform

End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.

No counterpart

Arize AI sells these in a stack layer with no product recorded for Insilico Medicine yet — nothing on the other side to compare them against.

AI agent

AlyxAI agent

AI engineering agent built into Arize AX that reads a project's traces, prompts, datasets and evals and acts on them — investigating issues, improving prompts and running evaluations from a full-page or side-chat surface whose context carries across pages.

Developer tool

Arize PhoenixDeveloper tool

Open-source platform for tracing, evaluating and experimenting with LLM and agent applications, run locally, via Docker/Kubernetes, or as free Phoenix Cloud instances.

Infrastructure service

Arize Database (adb)Infrastructure service

An AI-native datastore (built on Apache Iceberg) that unifies observability and evaluation data in open formats for zero-copy access across the AI/data stack.

Insilico Medicine sells these in a stack layer with no product recorded for Arize AI yet — nothing on the other side to compare them against.

Application

Science42: DORAApplication

AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.

inClinicoApplication

Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.

Hardware

PandaOmics BoxHardware

On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.